Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives $40.42 Consensus PT from Brokerages
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-one brokerages that are covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the […]
More Stories
Russia Bans Producers From Exporting Gasoline
By Guy Birchall Russia extended a temporary ban on gasoline exports to producers, Moscow said on April 2, citing the...
Who is Tiger Woods? Age, Marriage, Children, and Recent Controversy
Tiger Woods is one of the most famous American golfers. He is known as one of the greatest golf players...
Oil Falls, Stocks Jump on Renewed Hopes of Iran War Ending
By Tom Ozimek Oil prices dropped and stocks around the world rallied on April 1 on renewed hopes of a...
US Appeals Court Blocks Judge’s Rulings Against Trump Immigration Detention Policy
By Jack Phillips A U.S. appeals court on Tuesday halted a federal judge’s nationwide rulings that blocked the Trump administration...
Trump Says He’s Strongly Considering Pulling US Out of NATO
By Guy Birchall U.S. President Donald Trump said he is strongly considering withdrawing the United States from NATO, in comments...
Iran’s Top Leader Issues Statement Saying Regime Will Keep Backing Anti-Israel Forces
By Jack Phillips Iran’s top leader released a new statement on April 1 saying the Iranian regime will continue to...